Body Surface Gastric Mapping in Patients with GI Symptoms
The purpose of this study is to learn more about a new device that measures stomach myoelectric (electricity produced by muscles) activity in children and young adults using body surface gastric mapping (BSGM). The BSGM device is FDA approved in adults but not children under 18.
We are looking to partner with patients who have a confirmed diagnosis of a Motility Disorder and/or Functional Gastrointestinal Disorder (FGID) or patients who are having motility tests/procedures performed for clinical care. We are also looking for healthy controls without any history of inflammatory disease or pyloric disorders. All study participants must be 8 - 25 years of age and have a body mass index (BMI) of less than 35.
Participation is completely voluntary, and subjects may withdraw at any time without affecting their care. Participants may receive compensation for their time.